Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer

International Journal of Cancer

Volumn 87, Issue 1, 2000, Pages 110-117

  Sutcliffe, Siobhan ^a   Pharoah, Paul D P ^a,b   Easton, Douglas F ^a   Ponder, Bruce A J ^a   Ponder, B ^c   Easton, D ^c   Fraser, G ^c   Jacobs, I ^c   Mackay, J ^c   Twentyman, P ^c   Bishop, T ^c   Lowe, D ^c   Lakhani, S ^c   Steel, M ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIGENE FAMILY; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT;

AGE FACTORS; AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; REGISTRIES; RISK; TRANSCRIPTION FACTORS;

EID: 0034048140     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000701)87:1<110::AID-IJC16>3.0.CO;2-6     Document Type: Article

References (19)

1. CLAUS, E.B., RISCH, N. and THOMPSON, W.D., The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res. Treat., 28, 115-120 (1993).
2. DUPONT, W.D., Converting relative risks to absolute risks: a graphical approach. Stat. Med., 8, 641-651 (1989).
3. EASTON, D.F., FORD, D., BISHOP, D.T. and THE BREAST CANCER LINKAGE CONSORTIUM, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Amer. J. hum. Genet., 56, 265-271 (1995).
4. EASTON, D.F., MATTHEWS, F.E., FORD, D., SWERDLOW, A.J. and PETO, J., Cancer mortality in relatives of women with ovarian cancer: the OPCS study. Int. J. Cancer, 65, 284-294 (1996).
5. FERLAY, J., BLACK, R.J., WHELAN, S.L. and PARKIN, D.M., Electronic Database of cancer incidence in five continents. International Agency for Research On Cancer, Lyon, France (1997).
6. FORD, D., EASTON, D.F., BISHOP, D.T., NAROD, S.A., GOLDGAR, D.E. and THE BREAST CANCER LINKAGE CONSORTIUM, Risks of Cancer in BRCA1 mutation carriers. Lancet, 343, 692-695 (1994).
7. FORD, D. and 38 OTHERS, Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Amer. J. hum. Genet., 62, 676-689 (1998).
8. GAYTHER, S.A. and 15 OTHERS, Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature (Genet.), 11, 428-433 (1995).
9. GAYTHER, S.A., HARRINGTON, P., RUSSELL, P., KHARKEVICH, G., GARKAVTSEVA, R.F., PONDER, B.A.J. and THE UKCCCR FAMILIAL OVARIAN CANCER STUDY GROUP, Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Amer. J. hum. Genet., 58, 451-456 (1996).
10. GAYTHER, S.A., MANGION, J., RUSSELL, P., SEAL, S., BARFOOT, R., PONDER, B.A., STRATTON, M.R. and EASTON, D., Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature (Genet.), 15, 103-105 (1997).
11. GAYTHER, S.A., RUSSELL, P., HARRINGTON, P., ANTONIOU, A., EASTON, D.F. and PONDER, B.A.J., The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer and the implications for predictive testing. Amer. J. hum. Gen., 65, 1021-1029 (1999).
12. JISHI, M.F., ITNYRE, J.H., OAKLEY-GIRVAN, I.A., PIVER, M.S. and WHITTEMORE, A.S., Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry. Cancer, 76, 1416-1421 (1995).
13. KERBER, R.A. and SLATTERY, M.L., Comparison of self-reported and database-linked family history of cancer data in a case-control study. Amer. J. Epidemiol., 146, 244-248 (1997).
14. MIKI, Y. and 44 OTHERS., A strong candidate for the 17 linked breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71 (1994).
15. NAROD, S.A., FORD, D., DEVILEE, P., BARKARDOTTIR, R.B., LYNCH, H.T., SMITH, S.A., PONDER, B.A., WEBER, B.L., GARBER, J.E., BIRCH, J.M. and THE BREAST CANCER LINKAGE CONSORTIUM, An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Amer. J. hum. Genet., 56, 254-264 (1995).
16. SCHILDKRAUT, J.M and THOMPSON, W.D., Familial ovarian cancer: a population-based case-control study. Amer. J. Epidemiol., 128, 456-466 (1988).
17. STRATTON, J.F., PHAROAH, P.D.P., SMITH, S.K., EASTON, D.F. and PONDER, B.A.J., A systematic review and meta-analysis of family history and risk of ovarian cancer. Brit. J. Obst. Gynaecol., 105, 493-499 (1998).
18. STRUEWING, J.P., HARTGE, P., WACHOLDER, S., BAKER, S.M., BERLIN, M., MCADAMS, M., TIMMERMAN, M.M., BRODY, L.C. and TUCKER, M.A., The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med., 336, 1401-1408 (1997).
19. WOOSTER, R. and 40 OTHERS, Identification of the breast cancer susceptibility gene BRCA2. Nature (Lond.), 378, 789-792 (1995).